Document is current
Any future updates will be listed below
-
Authors
Koch, Edouard
Morel, Marion
Duchateau, Nathalie
-
Funding
Funding for this research was provided by:
Alcon (IIT#67562399)
- License Information
-
More Information
Article History
Received: 29 May 2025
Accepted: 9 October 2025
First Online: 19 November 2025
Declarations
:
: Dr Edouard Koch reports being a consultant for Alcon Healthcare.Dr Nathalie Duchateau and Marion Morel declare no competing interests.
: UIVA: uncorrected distance intermediate visual acuity, DCIVA: corrected distance intermediate visual acuity; * statistically significant differences ( p < 0.05).
: This study followed the tenets of the Decalaration of Helsinki and was approved by the Ethics Committee of the of the Hôtel-Dieu Hospital in Paris (ID-RCB No: 2022-A00089-34, NCT: 05416177). . Registered 01 september 2022. All recruited patients received a written information letter prior to enrollment. This study has been registered in the European Clinical Trials Register (EUdraCT: 2022-A00089-34).
